Case Study: Vernalis achieves reliable, high-performance endpoint protection with ESET

Research Company Vernalis Impressed with ESET’s Reliable

Vernalis, a world‑leading pharmaceutical research company focused on structure- and fragment-based drug discovery, needed a more reliable antivirus partner after their prior supplier’s software and UK support became unreliable. Seeking strong technical expertise, UK-based support and competitive pricing, Vernalis (via reseller CCS Media) selected ESET and adopted ESET Endpoint Antivirus as their replacement solution.

ESET, working with CCS Media, deployed ESET Endpoint Antivirus and provided dedicated account management and UK-based support, improving communication and responsiveness. The solution’s low system demands, virtualization support and advanced protection reduced software-related issues on Vernalis’s high‑performance compute clusters, minimized interruptions to research workflows, and left Vernalis extremely pleased with ESET’s reliability and support.

Vernalis

Martin Cox

Vernalis